• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

5

CATEGORIES

  • 11
  • 8

PRICE

0
0
19
19

PUBLISHED

0
2
17
19

PRODUCT TYPE

19

Search "Merz Pharmaceuticals, LLC-Detailed Product Pipeline" returned 19 results.

PRODUCT TITLE

Dyskinesia - Pipeline Review, H1 2014

Dyskinesia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Dyskinesia - Pipeline Review, H1 2014’, provides an overview of the Dyskinesia’s therapeutic pipeline. This report provides...

March 2014
FROM

Glaucoma - Pipeline Review, H1 2015

Glaucoma - Pipeline Review, H1 2015 Summary This, ‘Glaucoma - Pipeline Review, H1 2015’, provides an overview of the Glaucoma’s therapeutic pipeline. This report provides comprehensive information...

January 2015
FROM

Spasticity - Pipeline Review, H1 2014

Spasticity - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Spasticity - Pipeline Review, H1 2014’, provides an overview of the Spasticity’s therapeutic pipeline. This report provides...

April 2014
FROM

Spasticity - Pipeline Review, H2 2014

Spasticity - Pipeline Review, H2 2014 Summary This, ‘Spasticity - Pipeline Review, H2 2014’, provides an overview of the Spasticity’s therapeutic pipeline. This report provides comprehensive information...

October 2014
FROM

Alzheimer's Disease - Pipeline Review, H2 2014

Alzheimer's Disease - Pipeline Review, H2 2014 Summary This, ‘Alzheimer's Disease - Pipeline Review, H2 2014’, provides an overview of the Alzheimer's Disease’s therapeutic pipeline. This report...

October 2014
FROM

Dyskinesia - Pipeline Review, H2 2014

Dyskinesia - Pipeline Review, H2 2014 Summary This, ‘Dyskinesia - Pipeline Review, H2 2014’, provides an overview of the Dyskinesia’s therapeutic pipeline. This report provides comprehensive information...

August 2014
FROM

Cognitive Impairment - Pipeline Review, H1 2014

Cognitive Impairment - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Cognitive Impairment - Pipeline Review, H1 2014’, provides an overview of the Cognitive Impairment’s therapeutic pipeline. This...

March 2014
FROM

Autism - Pipeline Review, H2 2014

Autism - Pipeline Review, H2 2014 Summary This, ‘Autism - Pipeline Review, H2 2014’, provides an overview of the Autism’s therapeutic pipeline. This report provides comprehensive information on the...

September 2014
FROM

Autism - Pipeline Review, H1 2015

Autism - Pipeline Review, H1 2015 Summary This, ‘Autism - Pipeline Review, H1 2015’, provides an overview of the Autism’s therapeutic pipeline. This report provides comprehensive information on the...

January 2015
FROM

Autism - Pipeline Review, H1 2014

Autism - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Autism - Pipeline Review, H1 2014’, provides an overview of the Autism’s therapeutic pipeline. This report provides comprehensive...

March 2014
FROM

Tinnitus - Pipeline Review, H2 2014

Tinnitus - Pipeline Review, H2 2014 Summary This, ‘Tinnitus - Pipeline Review, H2 2014’, provides an overview of the Tinnitus’s therapeutic pipeline. This report provides comprehensive information...

September 2014
FROM

Alzheimer's Disease - Pipeline Review, H1 2014

Alzheimer's Disease - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Alzheimer's Disease - Pipeline Review, H1 2014’, provides an overview of the Alzheimer's Disease’s therapeutic pipeline. This...

February 2014
FROM

Age Related Macular Degeneration - Pipeline Review, H1 2014

Age Related Macular Degeneration - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Age Related Macular Degeneration - Pipeline Review, H1 2014’, provides an overview of the Age Related...

February 2014
FROM
Acne Vulgaris- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment Acne Vulgaris- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment - Product Thumbnail Image

Acne Vulgaris- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment

“ Acne Vulgaris- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014” provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication....

September 2014
FROM

Dementia - Pipeline Review, H1 2014

Dementia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Dementia - Pipeline Review, H1 2014’, provides an overview of the Dementia’s therapeutic pipeline. This report provides comprehensive...

June 2014
FROM
Athlete's Foot (Tinea Pedis)- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment Athlete's Foot (Tinea Pedis)- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment - Product Thumbnail Image

Athlete's Foot (Tinea Pedis)- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment

“ Athlete's Foot (Tinea Pedis)- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014” provides comprehensive insights about phase III pipeline drugs and marketed drugs across...

September 2014
FROM
Tinea Cruris (Jock Itch)- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment Tinea Cruris (Jock Itch)- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment - Product Thumbnail Image

Tinea Cruris (Jock Itch)- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment

“ Tinea Cruris (Jock Itch)- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014” provides comprehensive insights about phase III pipeline drugs and marketed drugs across...

September 2014
FROM
Tinea Corporis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment Tinea Corporis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment - Product Thumbnail Image

Tinea Corporis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment

“ Tinea Corporis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014” provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication....

September 2014
FROM
Onychomycosis (Tinea Unguium) Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment Onychomycosis (Tinea Unguium) Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment - Product Thumbnail Image

Onychomycosis (Tinea Unguium) Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment

“ Onychomycosis (Tinea Unguium)- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014” provides comprehensive insights about phase III pipeline drugs and marketed drugs...

September 2014
FROM
Loading Indicator

Our Clients

Procter & Gamble Co. Western Union Company Volvo Car Corporation Morgan Stanley SAP SE LG Corporation Roche Diagnostics Ltd.